144 related articles for article (PubMed ID: 8602519)
1. AIDS vaccine trial disappointing.
Science; 1996 Apr; 272(5260):341. PubMed ID: 8602519
[No Abstract] [Full Text] [Related]
2. Vaccines repress HIV in children.
AIDS Patient Care STDS; 1996 Dec; 10(6):381. PubMed ID: 11361573
[No Abstract] [Full Text] [Related]
3. A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
Coulaud IP; Gougeon ML; Gomard E; Descamps D; Lebon P; Aboulker JP; Bizzini B; Zagury D
AIDS; 1997 Jun; 11(7):937-8. PubMed ID: 9189226
[No Abstract] [Full Text] [Related]
4. Thailand trial for AIDS therapeutic vaccine?
Science; 1995 Sep; 269(5228):1207. PubMed ID: 7652565
[No Abstract] [Full Text] [Related]
5. Update on HIV vaccines.
Meldorf M; Corey L
STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
[TBL] [Abstract][Full Text] [Related]
6. First AIDS vaccine trial launched.
Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708
[No Abstract] [Full Text] [Related]
7. Therapeutic HIV vaccine from Spain.
Burton A
Lancet Infect Dis; 2001 Dec; 1(5):291. PubMed ID: 11871794
[No Abstract] [Full Text] [Related]
8. HIV vaccines. Viral envelope fails to deliver?
Bolognesi DP; Matthews TJ
Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
[No Abstract] [Full Text] [Related]
9. Therapeutic vaccines for chronic infections.
Autran B; Carcelain G; Combadiere B; Debre P
Science; 2004 Jul; 305(5681):205-8. PubMed ID: 15247470
[TBL] [Abstract][Full Text] [Related]
10. Progress in development and testing of novel recombinant vaccine platforms for HIV.
Weiner DB
Springer Semin Immunopathol; 2006 Nov; 28(3):195-6. PubMed ID: 17043866
[No Abstract] [Full Text] [Related]
11. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
12. Immune enhancement trial begins.
AIDS Patient Care STDS; 1996 Aug; 10(4):263. PubMed ID: 11361606
[No Abstract] [Full Text] [Related]
13. Vaccines for control of HIV infections.
Sharma KB
J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277
[No Abstract] [Full Text] [Related]
14. Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group.
DeMaria A; Kunches L; Mayer K; Cohen C; Epstein P; Werner B; Day J; DeCristofaro J; Landers S; Tang Y; Coady W
J Hum Virol; 2000; 3(4):182-92. PubMed ID: 10990166
[TBL] [Abstract][Full Text] [Related]
15. Policy rebuttal. HIV vaccine trial justified.
McNeil JG; Johnston MI; Birx DL; Tramont EC
Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
[No Abstract] [Full Text] [Related]
16. Keeping hope alive: HIV vaccines & the community.
Montecalvo M
Body Posit; 2004; 17(4):15-6. PubMed ID: 15929209
[No Abstract] [Full Text] [Related]
17. HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial.
Cohen J
Science; 2005 Aug; 309(5737):1003. PubMed ID: 16099960
[No Abstract] [Full Text] [Related]
18. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
19. Thailand's Prime-Boost HIV Vaccine Phase III.
Trinvuthipong C
Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
[No Abstract] [Full Text] [Related]
20. Vaccine against three kinds of HIV begins human tests.
AIDS Treat News; 2002 Nov; (385):4. PubMed ID: 12492040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
